Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 19

1.

The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain.

Elia AE, Rellos P, Haire LF, Chao JW, Ivins FJ, Hoepker K, Mohammad D, Cantley LC, Smerdon SJ, Yaffe MB.

Cell. 2003 Oct 3;115(1):83-95.

2.

Structure and function of Polo-like kinases.

Lowery DM, Lim D, Yaffe MB.

Oncogene. 2005 Jan 10;24(2):248-59. Review.

PMID:
15640840
3.

Polo-box domain: a versatile mediator of polo-like kinase function.

Park JE, Soung NK, Johmura Y, Kang YH, Liao C, Lee KH, Park CH, Nicklaus MC, Lee KS.

Cell Mol Life Sci. 2010 Jun;67(12):1957-70. doi: 10.1007/s00018-010-0279-9. Epub 2010 Feb 11. Review.

4.

Understanding the Polo Kinase machine.

Archambault V, Lépine G, Kachaner D.

Oncogene. 2015 Sep 10;34(37):4799-807. doi: 10.1038/onc.2014.451. Epub 2015 Jan 26. Review.

PMID:
25619835
5.

Plk1-targeted small molecule inhibitors: molecular basis for their potency and specificity.

Murugan RN, Park JE, Kim EH, Shin SY, Cheong C, Lee KS, Bang JK.

Mol Cells. 2011 Sep;32(3):209-20. doi: 10.1007/s10059-011-0126-3. Epub 2011 Jul 29. Review.

6.

From Plk1 to Plk5: functional evolution of polo-like kinases.

de Cárcer G, Manning G, Malumbres M.

Cell Cycle. 2011 Jul 15;10(14):2255-62. Epub 2011 Jul 15. Review.

7.

Functions of Polo-Like Kinases: A Journey From Yeast To Humans.

Vaid R, Sharma N, Chauhan S, Deshta A, Dev K, Sourirajan A.

Protein Pept Lett. 2016;23(2):185-97. Review.

PMID:
26786872
8.

Polo-like kinases inhibitors.

Garuti L, Roberti M, Bottegoni G.

Curr Med Chem. 2012;19(23):3937-48. Review.

PMID:
22709006
9.

Mechanisms underlying Plk1 polo-box domain-mediated biological processes and their physiological significance.

Lee KS, Park JE, Kang YH, Kim TS, Bang JK.

Mol Cells. 2014 Apr;37(4):286-94. doi: 10.14348/molcells.2014.0002. Epub 2014 Apr 7. Review.

10.

A case study from the chemistry core of the Pittsburgh Molecular Library Screening Center: the Polo-like kinase polo-box domain (Plk1-PBD).

Wipf P, Arnold D, Carter K, Dong S, Johnston PA, Sharlow E, Lazo JS, Huryn D.

Curr Top Med Chem. 2009;9(13):1194-205. Review.

PMID:
19807663
11.

Polo-like kinases: a team in control of the division.

van de Weerdt BC, Medema RH.

Cell Cycle. 2006 Apr;5(8):853-64. Epub 2006 Apr 17. Review.

PMID:
16627997
12.

The Plk3-Cdc25 circuit.

Myer DL, Bahassi el M, Stambrook PJ.

Oncogene. 2005 Jan 10;24(2):299-305. Review.

PMID:
15640846
13.

The Polo-box domain: a molecular integrator of mitotic kinase cascades and Polo-like kinase function.

Lowery DM, Mohammad DH, Elia AE, Yaffe MB.

Cell Cycle. 2004 Feb;3(2):128-31. Review. No abstract available.

PMID:
14712072
14.

The family of polo-like kinases.

Golsteyn RM, Lane HA, Mundt KE, Arnaud L, Nigg EA.

Prog Cell Cycle Res. 1996;2:107-14. Review.

PMID:
9552388
15.

Polo-like kinases: conservation and divergence in their functions and regulation.

Archambault V, Glover DM.

Nat Rev Mol Cell Biol. 2009 Apr;10(4):265-75. doi: 10.1038/nrm2653. Review. Erratum in: Nat Rev Mol Cell Biol. 2009 May;10(5):364.

PMID:
19305416
16.

[Targeting the substrate binding domain of polo-like kinase 1: advances in the study of PBD1 inhibitors].

Zhang L, Cao YH, Lu S, Sun SL, Liu HC, Lu T.

Yao Xue Xue Bao. 2013 Mar;48(3):315-24. Review. Chinese.

PMID:
23724641
17.

Polo-like kinases: structural variations lead to multiple functions.

Zitouni S, Nabais C, Jana SC, Guerrero A, Bettencourt-Dias M.

Nat Rev Mol Cell Biol. 2014 Jul;15(7):433-52. doi: 10.1038/nrm3819. Review.

PMID:
24954208
18.

Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment.

Liu X.

Transl Oncol. 2015 Jun;8(3):185-95. doi: 10.1016/j.tranon.2015.03.010. Review.

19.

Substrate and docking interactions in serine/threonine protein kinases.

Goldsmith EJ, Akella R, Min X, Zhou T, Humphreys JM.

Chem Rev. 2007 Nov;107(11):5065-81. Epub 2007 Oct 19. Review. No abstract available.

Supplemental Content

Support Center